IDOVEN
About Company
“Empowering cardiology with AI precision”
Idoven, founded in 2019 and based in Madrid, is a healthtech company that has developed the world’s first cardiology-as-a-service platform powered by artificial intelligence, aiming to augment a clinician’s ability to identify, triage, and diagnose patients at scale. The company’s AI technology, based on science, is trusted by leading Life Sciences and MedTech companies to drive innovation and better patient outcomes. Idoven’s platform offers solutions for MedTech, Life Sciences, and Preventative Screening Programs, providing digital diagnostics, cloud technology, deep neural network, digital biomarkers, prediction, risk stratification, and remote patient monitoring. The company is also involved in collaborative research and has a strong impact on cardiovascular care, with a focus on security, data privacy, and device neutrality. Additionally, Idoven is recognized and supported by leading institutions and has garnered investments from prominent figures like basketball legend Pau Gasol.